Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2013

Nov 18, 2013

34395_dirs_2013-11-18_f22deffe-6181-4946-9b78-59268dc54950.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-03-25

Reporting Person: Innes Guy Archibald (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-03-25 Common Stock P 57292 $114583.22 Acquired 926218 Direct
2013-11-14 Common Sotck P 4878 $7951.14 Acquired 931096 Direct
2013-11-14 Common Stock P 999 $1898.1 Acquired 932095 Direct

Footnotes

F1: The total 57,292 shares were acquired on March 25, 2013, of which 50,000 shares were purchased at a cost basis of $2.00 per share and 7,292 shares were acquired for the settlement of an existing debt valued at $14,583.22.

F2: The 4,878 shares were purchased at a cost basis of $1.63 per share.

F3: The 99 shares were purchased at a cost basis of $1.90 per share.

F4: P/J